Log in
Enquire now
Exosome Diagnostics

Exosome Diagnostics

A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.

OverviewStructured DataIssuesContributors

Contents

exosomedx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Diagnostic tools
Diagnostic tools
Molecular diagnostics
Molecular diagnostics
Biomedical engineering
Biomedical engineering
Diagnosis
Diagnosis
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
...
Location
Waltham, Massachusetts
Waltham, Massachusetts
0
Martinsried
Martinsried
0
Germany
Germany
New York City
New York City
New York
New York
B2X
B2B
B2B
0
CEO
‌
CHARLES (CHUCK) KUMMETH
0
Founder
‌
Shelly Hirshon
‌
James R. McCullough
AngelList URL
angel.co/exosome-diagnostics
Date Incorporated
2008
Number of Employees (Ranges)
51 – 2000
Email Address
info@exosomedx.com0
Phone Number
+161758805000
+4989416172700
Full Address
266 Second Ave, Suite 200, Waltham, MA 02451, US0
Am Klopferspitz 19a 82152 Martinsried Germany0
Investors
CD-Venture
CD-Venture
‌
Monashee Capital Corp
‌
Arcus Ventures
Qiagen
Qiagen
NGN Capital
NGN Capital
Forbion Capital Partners
Forbion Capital Partners
Founded Date
2008
Total Funding Amount (USD)
53,500,000
Latest Funding Round Date
March 2014
Competitors
Nanostics
Nanostics
CFO
‌
James T. Hippel
0
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
7
Wellfound ID
exosome-diagnostics
Country
United States
United States
0
Germany
Germany
0

Other attributes

Company Operating Status
Active
Public/Private
Private0
Wikidata ID
Q41568420

Exosome Diagnostics isolates exosomes, cell-derived vesicles, which contain RNA, DNA and proteins, from serum, plasma, urine, cerebralspinal fluid and saliva. The company performs molecular analysis of exosomes for diagnotics, disease detection, treatment and monitoring. Exosome Diagnostics collaborates with pharmaceutical companies such as Amgen and Takeda in research and development, biomarker discovery, validation and development of diagnostics.

While Chief Scientific Officer Johan Skog was at Massachusetts General Hospital, he was the first to demonstrate the detection of molecular mutations in a tumor in RNA extracted from exosomes in Nature Cell Biology in 2008.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Exosome Diagnostics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.